These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6983911)

  • 1. Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids.
    Jønsson V; Wells A; Klein G
    Cell Immunol; 1982 Sep; 72(2):263-76. PubMed ID: 6983911
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus binding to virus-carrying cell lines is enhanced in the presence of C3 and C3d.
    Wells A; Koide N; Eggertsen G; Lundwall A; Godal T; Steen HB; Klein G
    J Gen Virol; 1984 Mar; 65 ( Pt 3)():507-13. PubMed ID: 6321638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
    Nemerow GR; Wolfert R; McNaughton ME; Cooper NR
    J Virol; 1985 Aug; 55(2):347-51. PubMed ID: 2410629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
    Ahearn JM; Fearon DT
    Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
    [No Abstract]   [Full Text] [Related]  

  • 6. The Epstein-Barr virus receptor is distinct from the C3 receptor.
    Wells A; Koide N; Stein H; Gerdes J; Klein G
    J Gen Virol; 1983 Feb; 64 (Pt 2)():449-53. PubMed ID: 6300295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and functions of gp 140, the C3d/EBV receptor (CR2) of human B lymphocytes.
    Frade R
    Mol Immunol; 1986 Nov; 23(11):1249-53. PubMed ID: 2950318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
    Iida K; Nadler L; Nussenzweig V
    J Exp Med; 1983 Oct; 158(4):1021-33. PubMed ID: 6225820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
    Nemerow GR; Mold C; Schwend VK; Tollefson V; Cooper NR
    J Virol; 1987 May; 61(5):1416-20. PubMed ID: 3033269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
    Fingeroth JD; Weis JJ; Tedder TF; Strominger JL; Biro PA; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4510-4. PubMed ID: 6087328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities.
    Weis JJ; Richards SA; Smith JA; Fearon DT
    J Immunol Methods; 1986 Aug; 92(1):79-87. PubMed ID: 3018085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: implications for the relationship between African and American Burkitt's lymphoma.
    Freeman CB; Magrath IT; Benjamin D; Makuch R; Douglass EC; Santaella ML
    Clin Immunol Immunopathol; 1982 Oct; 25(1):103-13. PubMed ID: 7151335
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein.
    Nemerow GR; Siaw MF; Cooper NR
    J Virol; 1986 May; 58(2):709-12. PubMed ID: 2422399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for three binding sites for C3 (hemolytically inactive), C3b and C3d on a CR2-positive Burkitt lymphoma-derived cell line (Raji).
    Barile G; Di Renzo L; Lipari M; Frati L; Faggioni A
    FEBS Lett; 1993 Jun; 324(3):319-24. PubMed ID: 8405374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ; Tedder TF; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
    Weis JJ; Toothaker LE; Smith JA; Weis JH; Fearon DT
    J Exp Med; 1988 Mar; 167(3):1047-66. PubMed ID: 2832506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    Lambris JD; Ross GD
    J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement receptors.
    Holers VM
    Year Immunol; 1989; 4():231-40. PubMed ID: 2538973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.